A detailed history of Schonfeld Strategic Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 375,369 shares of BSX stock, worth $33 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
375,369
Previous 534,778 29.81%
Holding current value
$33 Million
Previous $36.6 Million 21.08%
% of portfolio
0.2%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $10.7 Million - $12.4 Million
-159,409 Reduced 29.81%
375,369 $28.9 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $3.22 Million - $3.84 Million
55,893 Added 11.67%
534,778 $36.6 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $11.2 Million - $13.3 Million
229,757 Added 92.22%
478,885 $27.7 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $5.2 Million - $5.66 Million
103,528 Added 71.1%
249,128 $13.2 Million
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $20.9 Million - $22.9 Million
-419,515 Reduced 74.24%
145,600 $7.88 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $4.52 Million - $5.01 Million
100,225 Added 21.56%
565,115 $28.3 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $7.88 Million - $9.4 Million
199,172 Added 74.96%
464,890 $21.5 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $5.67 Million - $16.9 Million
154,546 Added 139.02%
265,718 $10.3 Million
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $5.73 Million - $7.66 Million
-162,551 Reduced 59.39%
111,172 $4.14 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $4.54 Million - $5.01 Million
111,023 Added 68.24%
273,723 $12.1 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $4.07 Million - $4.79 Million
106,800 Added 191.06%
162,700 $6.91 Million
Q3 2021

Nov 16, 2021

SELL
$41.23 - $45.88 $11.5 Million - $12.8 Million
-278,900 Reduced 83.3%
55,900 $2.43 Million
Q2 2021

Nov 16, 2021

SELL
$38.58 - $44.24 $1.54 Million - $1.77 Million
-40,000 Reduced 10.67%
334,800 $14.3 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $10.4 Million - $11.9 Million
-268,967 Reduced 41.78%
374,800 $16 Million
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $11.2 Million - $12.6 Million
318,782 Added 98.09%
643,767 $24.9 Million
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $6.46 Million - $8.18 Million
194,819 Added 149.67%
324,985 $11.7 Million
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $2.9 Million - $3.56 Million
84,206 Added 183.22%
130,166 $5,000
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $497,591 - $644,611
16,482 Added 55.91%
45,960 $1.61 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $511,769 - $905,652
-19,813 Reduced 40.2%
29,478 $962,000
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $1.57 Million - $1.88 Million
41,530 Added 535.11%
49,291 $2.23 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $267,618 - $288,464
-6,639 Reduced 46.1%
7,761 $316,000
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $8.22 Million - $10.1 Million
-235,600 Reduced 94.24%
14,400 $619,000
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $536,433 - $664,225
16,300 Added 6.97%
250,000 $9.6 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $3.7 Million - $4.55 Million
-116,500 Reduced 33.27%
233,700 $8.26 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $1.01 Million - $1.19 Million
-30,682 Reduced 8.06%
350,200 $13.5 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $1.44 Million - $1.84 Million
53,488 Added 16.34%
380,882 $12.5 Million
Q1 2018

May 15, 2018

BUY
$25.2 - $28.54 $530,737 - $601,080
21,061 Added 6.88%
327,394 $8.94 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $52,306 - $62,878
2,110 Added 0.69%
306,333 $7.6 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $7.99 Million - $8.87 Million
304,223
304,223 $8.88 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $126B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.